Cargando…

Ayahuasca potential benefits

INTRODUCTION: Ayahusca has potential therapeutic beneffits. OBJECTIVES: Expose the potential beneffits of ayahuasca from neuropharmacology and clinical existing evidence. METHODS: A literature review was carried out in the databases pubmed, clinical key and texts of scientific dissemination. RESULTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinilla, R., Rodriguez, C., Batet-Sanchez, D., Ordoñez, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479972/
http://dx.doi.org/10.1192/j.eurpsy.2021.2043
_version_ 1784790925473480704
author Pinilla, R.
Rodriguez, C.
Batet-Sanchez, D.
Ordoñez, B.
author_facet Pinilla, R.
Rodriguez, C.
Batet-Sanchez, D.
Ordoñez, B.
author_sort Pinilla, R.
collection PubMed
description INTRODUCTION: Ayahusca has potential therapeutic beneffits. OBJECTIVES: Expose the potential beneffits of ayahuasca from neuropharmacology and clinical existing evidence. METHODS: A literature review was carried out in the databases pubmed, clinical key and texts of scientific dissemination. RESULTS: There´s scientific literature about the potential therapeutic use of ayahuasca in dependencies, anxiety symtoms and depression, near death experiences and terminal illnesses. Possible benefit is postulated in impulsivity and personality disorders. It induces an introspective state, triggered by thoughts, emotions and autobiographical memories, which promotes reflection on personal issues, allowing new perspectives on certain life issues. It is common for users to describe it as analogous to a psychotherapeutic intervention. 5HTA2 agonists stimulate the expression of genes that encode transcription factors such as c-fos, egr 1, egr 2 and brain-derived neurotrophic factor (BDNF), which influence neuronal plasticity and are associated with cognitive aspects such as memory and attention. MAOIs and 5HT2A agonism have anxiolytic and antidepressant effects. Sigma -1 agonism promotes neuroplasticity. Decrease and remission in the consumption of alcohol and cocaine has been reported in patients with abuse and dependence. There has been significant decrease in depressive symptomatology, in observational studies, cases and controls and double blind compared with placebo. Improvement in different domains measured with mindfulness scales, similar to those observed in meditators, suggests an association between mindfulness techniques and experiences with ayahuasca. CONCLUSIONS: There is existing evidence about potential therapeutical uses of ayahuasca. More studies are needed with biger samples, to establish it´s clinical use. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9479972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94799722022-09-29 Ayahuasca potential benefits Pinilla, R. Rodriguez, C. Batet-Sanchez, D. Ordoñez, B. Eur Psychiatry Abstract INTRODUCTION: Ayahusca has potential therapeutic beneffits. OBJECTIVES: Expose the potential beneffits of ayahuasca from neuropharmacology and clinical existing evidence. METHODS: A literature review was carried out in the databases pubmed, clinical key and texts of scientific dissemination. RESULTS: There´s scientific literature about the potential therapeutic use of ayahuasca in dependencies, anxiety symtoms and depression, near death experiences and terminal illnesses. Possible benefit is postulated in impulsivity and personality disorders. It induces an introspective state, triggered by thoughts, emotions and autobiographical memories, which promotes reflection on personal issues, allowing new perspectives on certain life issues. It is common for users to describe it as analogous to a psychotherapeutic intervention. 5HTA2 agonists stimulate the expression of genes that encode transcription factors such as c-fos, egr 1, egr 2 and brain-derived neurotrophic factor (BDNF), which influence neuronal plasticity and are associated with cognitive aspects such as memory and attention. MAOIs and 5HT2A agonism have anxiolytic and antidepressant effects. Sigma -1 agonism promotes neuroplasticity. Decrease and remission in the consumption of alcohol and cocaine has been reported in patients with abuse and dependence. There has been significant decrease in depressive symptomatology, in observational studies, cases and controls and double blind compared with placebo. Improvement in different domains measured with mindfulness scales, similar to those observed in meditators, suggests an association between mindfulness techniques and experiences with ayahuasca. CONCLUSIONS: There is existing evidence about potential therapeutical uses of ayahuasca. More studies are needed with biger samples, to establish it´s clinical use. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9479972/ http://dx.doi.org/10.1192/j.eurpsy.2021.2043 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Pinilla, R.
Rodriguez, C.
Batet-Sanchez, D.
Ordoñez, B.
Ayahuasca potential benefits
title Ayahuasca potential benefits
title_full Ayahuasca potential benefits
title_fullStr Ayahuasca potential benefits
title_full_unstemmed Ayahuasca potential benefits
title_short Ayahuasca potential benefits
title_sort ayahuasca potential benefits
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479972/
http://dx.doi.org/10.1192/j.eurpsy.2021.2043
work_keys_str_mv AT pinillar ayahuascapotentialbenefits
AT rodriguezc ayahuascapotentialbenefits
AT batetsanchezd ayahuascapotentialbenefits
AT ordonezb ayahuascapotentialbenefits